España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Quipt Home Medical
QIPT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.94
-0.02
-0.68%
At close: -
$2.98
0.04
1.36%
After Hours: 8:08 AM EDT
Get Report
Comment
Quipt Home Medical (QIPT) Forecast
News
Earnings
Quipt Home Medical (QIPT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Quipt Home Medical (NASDAQ:QIPT) Stock
Quipt Home Medical Stock (NASDAQ: QIPT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Quipt Home Medical shares are trading lower a...
Benzinga Newsdesk
Monday, December 16, 2024
Quipt Home Medical Q4 Sales $61.30M Miss $64....
Benzinga Newsdesk
Earnings Scheduled For December 16, 2024
Benzinga Insights
Friday, December 13, 2024
Earnings Preview For Quipt Home Medical
Benzinga Insights
Exploring Quipt Home Medical's Earnings Expectations
Benzinga Insights
Wednesday, August 21, 2024
Benchmark Maintains Buy on Quipt Home Medical...
Benzinga Newsdesk
Friday, August 16, 2024
Canaccord Genuity Maintains Buy on Quipt Home...
Benzinga Newsdesk
Thursday, August 15, 2024
Quipt Home Medical shares are trading lower a...
Benzinga Newsdesk
Wednesday, August 14, 2024
Quipt Home Medical Q3 2024 GAAP EPS $(0.04) M...
Benzinga Newsdesk
Monday, May 20, 2024
Benchmark Maintains Buy on Quipt Home Medical...
Benzinga Newsdesk
Friday, May 17, 2024
Canaccord Genuity Maintains Buy on Quipt Home...
Benzinga Newsdesk
Wednesday, May 15, 2024
Quipt Home Medical Q2 2024 GAAP EPS $(0.03) M...
Benzinga Newsdesk
Thursday, May 09, 2024
Quipt Home Medical Announces Filing Of Final ...
Benzinga Newsdesk
Friday, February 16, 2024
Raymond James Downgrades Quipt Home Medical t...
Benzinga Newsdesk
Wednesday, February 14, 2024
Quipt Home Medical Q1 EPS $(0.01) Down From $...
Benzinga Newsdesk
Earnings Scheduled For February 14, 2024
Benzinga Insights
Tuesday, February 13, 2024
Quipt Home Medical Earnings Preview
Benzinga Insights
Wednesday, December 20, 2023
Benchmark Reiterates Buy on Quipt Home Medica...
Benzinga Newsdesk
Monday, December 18, 2023
Quipt Home Medical Q4 EPS $(0.03) Down From $...
Benzinga Newsdesk
Earnings Scheduled For December 18, 2023
Benzinga Insights
HEICO, EMCOR Group And 3 Stocks To Watch Heading Into Monday
Avi Kapoor
Investor Sentiment Falls But Fear & Greed Index Remains In 'Greed' Zone
Avi Kapoor
Friday, December 15, 2023
Earnings Preview: Quipt Home Medical
Benzinga Insights
Quipt Home Medical's Earnings Outlook
Benzinga Insights
Monday, September 11, 2023
Quipt Announces Multi-State Acquisition Addin...
Benzinga Newsdesk
Tuesday, August 15, 2023
Earnings Scheduled For August 15, 2023
Benzinga Insights
Monday, August 14, 2023
Quipt Home Medical Q3 Sales $60.30M Beat $60....
Benzinga Newsdesk
Earnings Preview For Quipt Home Medical
Benzinga Insights
Tuesday, June 20, 2023
Quipt Home Medical Announces Up-listing to th...
Benzinga Newsdesk
Wednesday, June 14, 2023
Canaccord Genuity Assumes Quipt Home Medical ...
Benzinga Newsdesk
Thursday, June 01, 2023
Quipt Home Medical Announces Termination Pf A...
Benzinga Newsdesk
Wednesday, May 17, 2023
Benchmark Reiterates Buy on Quipt Home Medica...
Benzinga Newsdesk
Tuesday, May 16, 2023
Quipt Home Medical: Q2 Earnings Insights
Benzinga Insights
Monday, May 15, 2023
Quipt Home Medical's Earnings Outlook
Benzinga Insights
Monday, April 17, 2023
Quipt Home Medical Announces $35M Bought Deal Public Offering Of 4.46M Shares At A Price Of $7.85/Share And ~$2M Private Placement
Happy Mohamed
Tuesday, April 04, 2023
Quipt Home Medical Executes National Insuranc...
Benzinga Newsdesk
Wednesday, February 15, 2023
Benchmark Reiterates Buy on Quipt Home Medica...
Benzinga Newsdesk
Tuesday, February 14, 2023
Quipt Home Medical Expects Margins To Remain ...
Benzinga Newsdesk
Quipt Home Medical Q1 EPS $0.01 Versus $(0.06...
Benzinga Newsdesk
Monday, February 13, 2023
Earnings Scheduled For February 13, 2023
Benzinga Insights
Benchmark Reiterates Buy on Quipt Home Medica...
Benzinga Newsdesk
Friday, February 10, 2023
Preview: Quipt Home Medical's Earnings
Benzinga Insights
Wednesday, January 04, 2023
Quipt Home Medical shares are trading higher ...
Michael Horton
Tuesday, January 03, 2023
Quipt Home Medical Shares Resume Trade
Michael Horton
Great Elm Group Announces Closing Of Sale Of Majority Interest In Co.'s Durable Medical Equipment Business To QHM For $80M
Michael Horton
Quipt Home Medical Shares Halted On Code News...
Benzinga Newsdesk
Wednesday, December 21, 2022
Quipt Home Medical Q4 EPS $0.05 Beats $0.02 Estimate, Sales $40.09M Miss $40.57M Estimate
Michael Horton
Earnings Scheduled For December 21, 2022
Benzinga Insights
Tuesday, December 20, 2022
Earnings Outlook For Quipt Home Medical
Benzinga Insights
Wednesday, October 12, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Show More
